Highlights

[MKH] Change In Director's Shareholding - DATUK CHEN FOOK WAH on 06-Mar-2015


Stock [MKH]: MKH BHD
Announcement Date 06-Mar-2015

Director's Particular:

Name DATUK CHEN FOOK WAH

Details of Changes:

Currency Malaysian Ringgit (MYR)

Date of Change Type Number of Shares Price
04-Mar-2015 Acquired 12,208 2.900

Nature of Interest Direct Interest
Shares Ordinary Shares of RM 1.00 each
Reason Acquisition of shares via open market
Consideration

Total no of securities after change

Direct (units) 617,800
Direct (%) 0.15
Indirect (units) 173,719,402
Indirect (%) 41.42
Total (units) 174,337,202
Total (%) 41.57
Date of Notice 06-Mar-2015


  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Stock Screener using Technical and Fundamental criteria
MQ Affiliate
Join the MQ Affiliate Program today to earn rewards
 
 

614  229  596  731 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 EFRAME 0.37+0.025 
 AT 0.09+0.01 
 KANGER 0.17-0.005 
 VC 0.055+0.005 
 MAHSING 1.00+0.02 
 VIVOCOM 0.0450.00 
 LUSTER 0.170.00 
 MRDIY 1.74-0.01 
 MLAB 0.020.00 
 SUPERMX 9.78+0.57 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. LION IN THE DEN SLEEPING, WAITING TO POUNCE !!! Bursa Master
2. DOW CRASHED BY 650 POINTS ? NO FEAR AT ALL IF YOU KNOW THIS STOCK PROSPERED DURING ASIAN FINANCIAL CRISIS & SUBPRIME CRISIS OF 2007/8 COLLAPSE (WHAT? THE INVESTMENT APPROACH OF CALVIN TAN
3. Najib Facebook Post comments on GLOVES. What's the message? gloveharicut
4. Traders Brief 26 Oct 2020 - Key Support At 200D SMA To Prevent Further Slide HLBank Research Highlights
5. US has 2 Incurable Chronic Diseases - Koon Yew Yin Koon Yew Yin's Blog
6. Traders Brief 27 Oct 2020 - Volatility Ahead Amid Internal and External Headwinds HLBank Research Highlights
7. LUXCHEM RESULT VERSUS HARTALEGA RESULT (COMPARE & CONTRAST) Calvin Tan Research THE INVESTMENT APPROACH OF CALVIN TAN
8. Supermax: The Best Is Yet To Come- Myth or Truth Van Gogh of Financial
PARTNERS & BROKERS